Tag: sphygmomanometer market growth

Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.

Sphygmomanometer Market Expansion Outlook: What Revenue Opportunities Are Ahead?

The sphygmomanometer market has seen considerable expansion in recent years. It is forecast to grow from $3.2 billion in 2025 to $3.53 billion in 2026, at a compound annual growth rate (CAGR) of 10.3%. The historical increase can be ascribed to the rising prevalence of hypertension, the extensive past use of mercury-based devices, augmented screening in clinical environments, the development of primary healthcare facilities, and the adoption of manual and aneroid devices.

The sphygmomanometer market size is anticipated to experience substantial growth in the upcoming years. It will grow to $5.31 billion in 2030 at a compound annual growth rate (CAGR) of 10.7%. The expansion foreseen in this period can be ascribed to an escalating demand for remote patient monitoring, the increasing adoption of connected healthcare devices, the broadening of telemedicine services, a heightened focus on preventive cardiovascular care, and the ongoing replacement of mercury-based devices. Prominent trends for the forecast period include a greater acceptance of digital blood pressure monitoring devices, a rising demand for home-based monitoring solutions, the increasing integration of data connectivity features, the proliferation of portable and wearable configurations, and an enhanced emphasis on measurement accuracy and user-friendliness.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=81080912&type=smp&name=Sphygmomanometer%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Sphygmomanometer Market Growth Factors: What’s Supporting Expansion?

The increasing prevalence of chronic non-communicable diseases (NCDs) is anticipated to drive the expansion of the sphygmomanometer market in the future. These long-term health conditions, particularly hypertension and cardiovascular disease, develop gradually and demand continuous surveillance and management. Hypertension poses a significant global health risk and is a primary contributor to cardiovascular issues, thus making consistent blood pressure measurements crucial for early detection and effective intervention. The escalating occurrence of these conditions is influenced by lifestyle elements like an aging global populace, unhealthy eating habits, insufficient physical activity, and rising rates of obesity, all of which contribute to an increase in blood-pressure irregularities worldwide. Sphygmomanometers play a vital role in patient care by facilitating prompt diagnosis, ongoing monitoring, and enhanced cardiovascular risk management in both medical facilities and home environments. For instance, in September 2025, the World Health Organization (WHO), a Switzerland-based agency of the United Nations, reported on the significant global impact of hypertension, estimating that 1.4 billion adults aged 30–79 were affected in 2024—representing 33 percent of this age group—with two-thirds living in low- and middle-income countries. Additionally, approximately 600 million individuals (44 percent) were undiagnosed, and about 630 million (44 percent) had received a diagnosis and treatment. Consequently, the growing incidence of chronic NCDs is fueling the expansion of the sphygmomanometer market.

Sphygmomanometer Market Segment Analysis Spotlighting Growth Areas

The sphygmomanometer market covered in this report is segmented –

1) By Product: Electronic Sphygmomanometer, Aneroid Sphygmomanometer, Mercury Sphygmomanometer

2) By Configuration: Portable, Desk Mounted, Floor Standing, Wall Mounted

3) By Operation: Electric, Manual, Automatic, Semi-automatic

4) By End User: Hospitals, Ambulatory Surgical Centers And Clinics, Home Healthcare, Other End Users

Subsegments:

1) By Electronic Sphygmomanometer: Upper Arm Electronic Sphygmomanometer, Wrist Electronic Sphygmomanometer, Finger Electronic Sphygmomanometer

2) By Aneroid Sphygmomanometer: Manual Aneroid Sphygmomanometer, Digital Aneroid Sphygmomanometer

3) By Mercury Sphygmomanometer: Standard Mercury Sphygmomanometer, Portable Mercury Sphygmomanometer

Sphygmomanometer Market Industry Trends: What’s Reshaping Demand?

Leading companies in the sphygmomanometer market are concentrating on developing sophisticated automatic blood pressure monitoring solutions that integrate AI-driven diagnostic features to enhance measurement accuracy, aid in the early detection of cardiovascular abnormalities, and boost the convenience of home-based health monitoring. These AI-enabled automatic blood pressure monitors utilize machine-learning algorithms to analyze pulse-wave signals during cuff inflation, allowing the device to identify irregular heart rhythms such as atrial fibrillation (AFib) while providing reliable systolic and diastolic readings. For instance, in November 2024, OMRON Healthcare, a Japan-based health equipment, software, and service provider, obtained FDA De Novo authorization for its next-generation home blood pressure monitor equipped with IntelliSense AFib, an AI-powered AFib detection algorithm that evaluates more than 300 pulse-wave indices and demonstrates high diagnostic accuracy, with clinical performance showing 95% sensitivity and 98% specificity. This innovation underscores how automatic oscillometric devices are transforming from simple blood-pressure measurement tools into comprehensive cardiovascular screening technologies that support early detection, continuous monitoring, and improved clinical decision-making.

Sphygmomanometer Market Company Landscape And Competitive Strategy

Major companies operating in the sphygmomanometer market are A&D Company Ltd., American Diagnostic Corporation, Omron Healthcare Inc., Microlife Corporation, Beurer GmbH, CIGA Healthcare Ltd., Rossmax International Ltd., Rudolf Riester GmbH, Welch Allyn Inc., Koninklijke Philips N.V., Paul Hartmann AG, Spengler, Holtex Ltd., Timesco Healthcare Ltd., Bremed Ltd., iHealth Labs Inc., Contec Medical Systems Co. Ltd., SunTech Medical Inc., General Electric Company, Amico Group of Companies, HEINE Optotechnik GmbH and Co. KG, Hill-Rom Services Inc., Halma plc

View The Full Sphygmomanometer Market Report:

https://thebusinessresearchcompany.com/report/sphygmomanometer-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Sphygmomanometer Market Largest Region: Which Geography Holds The Highest Market Share?

North America was the largest region in the sphygmomanometer market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global sphygmomanometer market during the forecast period. The regions covered in the sphygmomanometer market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

The market for sphygmomanometers has experienced significant growth recently, driven by increasing health awareness and advances in medical technology. This sector continues to evolve rapidly, influenced by rising rates of hypertension and a shift toward more modern, connected healthcare devices. Below, we explore the current market size, key drivers, segmentation, emerging trends, leading players, and regional outlook shaping the future of the sphygmomanometer industry.

Sphygmomanometer Market Size and Expected Growth Trajectory

The sphygmomanometer market has expanded steadily in recent years and is projected to grow from $3.2 billion in 2025 to $3.53 billion in 2026, at a compound annual growth rate (CAGR) of 10.3%. This growth during the past period is largely due to the increasing prevalence of hypertension, the historical reliance on mercury-based devices, more frequent clinical screenings, the expansion of primary healthcare centers, and ongoing use of manual and aneroid models.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10396&type=smp

Looking ahead, the market is expected to grow even faster, reaching $5.31 billion by 2030 with a CAGR of 10.7%. This forecasted increase is driven by rising demand for remote patient monitoring, wider adoption of connected healthcare technology, growth in telemedicine services, a stronger focus on preventive cardiovascular care, and the gradual replacement of mercury-based sphygmomanometers. Key trends include the growing popularity of digital blood pressure monitors, the surge in home-based monitoring, integration of data connectivity, portable and wearable device options, and an emphasis on accuracy and user-friendliness.

Factors Behind Rising Demand in the Sphygmomanometer Market

A major contributor to market growth is the escalating burden of chronic non-communicable diseases (NCDs), especially hypertension and cardiovascular disorders. These long-term conditions progress slowly and require continuous monitoring and management. Hypertension, in particular, is a significant global health issue and a leading risk factor for cardiovascular complications, making regular blood pressure monitoring critical for early diagnosis and effective treatment.

Access The Complete Sphygmomanometer Market Report:

https://www.thebusinessresearchcompany.com/report/sphygmomanometer-global-market-report

Lifestyle factors such as an aging global population, unhealthy diets, reduced physical activity, and increasing obesity rates are fueling the rise in blood pressure irregularities worldwide. Sphygmomanometers are essential tools for timely diagnosis, ongoing monitoring, and enhanced management of cardiovascular risks in both clinical environments and home settings. For example, the World Health Organization (WHO) reported that in 2024, approximately 1.4 billion adults aged 30 to 79 were living with hypertension, constituting 33 percent of this demographic. Notably, two-thirds of these individuals reside in low- and middle-income countries, with about 600 million undiagnosed and roughly 630 million receiving treatment. This substantial global health challenge is a key factor driving sphygmomanometer market expansion.

How the Growth of Ambulatory Surgery Centers is Boosting Market Demand

Another important driver for the sphygmomanometer market is the rapid increase in ambulatory surgery centers (ASCs). These specialized medical facilities focus on performing surgical procedures that do not require overnight hospitalization. ASCs depend heavily on sphygmomanometers—commonly known as blood pressure cuffs—to monitor patients’ vital signs before, during, and after surgeries.

In the United States, the number of ambulatory surgery centers is growing steadily. According to CliftonLarsonAllen LLP, as of July 2025, there are over 10,000 ASCs nationwide, with industry revenues projected to rise from approximately $45 billion in 2024 to about $57 billion by 2030. This expansion underscores the increasing demand for sphygmomanometers within these facilities, further stimulating market growth.

Detailed Segmentation of the Sphygmomanometer Market

This market is segmented by product type, configuration, operation mode, and end user. The product categories include Electronic Sphygmomanometers, Aneroid Sphygmomanometers, and Mercury Sphygmomanometers. Configurations are divided into Portable, Desk Mounted, Floor Standing, and Wall Mounted devices. Operational types cover Electric, Manual, Automatic, and Semi-automatic models. End users comprise Hospitals, Ambulatory Surgical Centers and Clinics, Home Healthcare, and other sectors.

Further breakdowns include subtypes such as Upper Arm, Wrist, and Finger Electronic Sphygmomanometers; Manual and Digital Aneroid types; and Standard versus Portable Mercury Sphygmomanometers, allowing for a comprehensive understanding of the market’s structure.

Innovations and Trends Driving the Future of the Sphygmomanometer Market

Leading companies are increasingly focusing on developing advanced automatic blood pressure monitors that incorporate AI-driven diagnostic technologies. These innovations aim to enhance measurement accuracy, facilitate early detection of cardiovascular irregularities, and improve the convenience of home health monitoring.

For example, in November 2024, OMRON Healthcare, a Japan-based company specializing in health equipment, received FDA De Novo authorization for its next-generation home blood pressure monitor featuring IntelliSense AFib. This AI-powered atrial fibrillation detection algorithm analyzes over 300 pulse-wave indices, achieving clinical performance with 95% sensitivity and 98% specificity. This advancement highlights the transformation of automatic oscillometric devices from simple blood pressure tools into comprehensive cardiovascular screening technologies, supporting early diagnosis, ongoing monitoring, and better clinical decision-making.

Key Players Leading the Sphygmomanometer Market Competition

The sphygmomanometer market features several prominent companies driving innovation and competition. Notable players include A&D Company Ltd., American Diagnostic Corporation, Omron Healthcare Inc., Microlife Corporation, Beurer GmbH, CIGA Healthcare Ltd., Rossmax International Ltd., Rudolf Riester GmbH, Welch Allyn Inc., Koninklijke Philips N.V., Paul Hartmann AG, Spengler, Holtex Ltd., Timesco Healthcare Ltd., Bremed Ltd., iHealth Labs Inc., Contec Medical Systems Co. Ltd., SunTech Medical Inc., General Electric Company, Amico Group of Companies, HEINE Optotechnik GmbH & Co. KG, Hill-Rom Services Inc., and Halma plc.

Regional Market Leadership and Growth Forecast

In 2025, North America held the largest share of the global sphygmomanometer market due to its advanced healthcare infrastructure and technology adoption. However, the Asia-Pacific region is anticipated to be the fastest-growing market during the forecast period, driven by increasing healthcare investments and rising awareness about cardiovascular health. The market analysis covers key territories including Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, offering a broad perspective on regional market dynamics.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Is The Forecasted Rise In Market Size Of The Sphygmomanometer Market During The Forecast Period?

The sphygmomanometer market has seen significant expansion in recent times. It is projected to grow from $3.2 billion in 2025 to $3.53 billion in 2026, at a compound annual growth rate (CAGR) of 10.3%. Historically, this growth can be attributed to the rising prevalence of hypertension, the widespread use of mercury-based devices in the past, increased screening in clinical settings, the expansion of primary healthcare facilities, and the adoption of manual and aneroid devices.

The sphygmomanometer market is anticipated to experience substantial growth in the upcoming years. It is projected to expand to $5.31 billion by 2030, achieving a compound annual growth rate (CAGR) of 10.7%. This expansion during the forecast period can be attributed to factors such as the increasing need for remote patient monitoring, the rising acceptance of connected healthcare devices, the broadening of telemedicine services, a greater focus on preventive cardiovascular care, and the growing replacement of mercury-based devices. Key trends expected in this period include the increased adoption of digital blood pressure monitoring tools, a growing demand for home-based monitoring options, the expanding integration of data connectivity functionalities, the development of portable and wearable designs, and an enhanced emphasis on measurement precision and user convenience.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10396&type=smp

What Major Growth Factors Are Impacting The Sphygmomanometer Market?

The increasing prevalence of chronic non-communicable diseases (NCDs) is anticipated to fuel the expansion of the sphygmomanometer market. These NCDs, particularly hypertension and cardiovascular disease, are persistent health issues characterized by gradual progression, demanding continuous oversight and care. Hypertension poses a significant worldwide health challenge and is a leading contributor to cardiovascular problems, emphasizing the critical need for routine blood-pressure checks to facilitate prompt diagnosis and successful therapy. The rising incidence of these ailments stems from lifestyle elements including an aging global population, poor dietary habits, lack of physical activity, and escalating obesity levels, all of which contribute to widespread blood-pressure imbalances. Sphygmomanometers play a vital role in patient care, facilitating early diagnosis, consistent monitoring, and enhanced management of cardiovascular risks in both medical facilities and home environments. For example, data from the World Health Organization (WHO), a United Nations agency based in Switzerland, reported in September 2025, underscored the considerable global impact of hypertension, with approximately 1.4 billion adults aged 30–79 affected in 2024, accounting for 33 percent of this demographic. Of these, two-thirds lived in low- and middle-income nations, while approximately 600 million people (44 percent) were undiagnosed, and about 630 million individuals (44 percent) had received a diagnosis and treatment. Consequently, the increasing burden of chronic NCDs is a key factor propelling the expansion of the sphygmomanometer market.

What Segment Types Are Included In The Sphygmomanometer Market Analysis?

The sphygmomanometer market covered in this report is segmented –

1) By Product: Electronic Sphygmomanometer, Aneroid Sphygmomanometer, Mercury Sphygmomanometer

2) By Configuration: Portable, Desk Mounted, Floor Standing, Wall Mounted

3) By Operation: Electric, Manual, Automatic, Semi-automatic

4) By End User: Hospitals, Ambulatory Surgical Centers And Clinics, Home Healthcare, Other End Users

Subsegments:

1) By Electronic Sphygmomanometer: Upper Arm Electronic Sphygmomanometer, Wrist Electronic Sphygmomanometer, Finger Electronic Sphygmomanometer

2) By Aneroid Sphygmomanometer: Manual Aneroid Sphygmomanometer, Digital Aneroid Sphygmomanometer

3) By Mercury Sphygmomanometer: Standard Mercury Sphygmomanometer, Portable Mercury Sphygmomanometer

Which Trends Are Influencing The Direction Of The Sphygmomanometer Market?

Leading companies in the sphygmomanometer market are concentrating on developing sophisticated automatic blood pressure monitoring solutions. These solutions integrate AI-driven diagnostic features to enhance measurement accuracy, support the early detection of cardiovascular abnormalities, and boost the convenience of home-based health monitoring. AI-enabled automatic blood pressure monitors utilize machine-learning algorithms to analyze pulse-wave signals during cuff inflation, allowing the device to detect irregular heart rhythms such as atrial fibrillation (AFib) while providing reliable systolic and diastolic readings. For instance, in November 2024, OMRON Healthcare, a Japan-based health equipment, software, and service provider, received FDA De Novo authorization for its next-generation home blood pressure monitor equipped with IntelliSense AFib. This AI-powered AFib detection algorithm evaluates more than 300 pulse-wave indices, demonstrating high diagnostic accuracy, with clinical performance showing 95% sensitivity and 98% specificity. This innovation underscores how automatic oscillometric devices are evolving from simple blood-pressure measurement tools into comprehensive cardiovascular screening technologies that support early detection, continuous monitoring, and improved clinical decision-making.

Who Are The Prominent Players Across The Sphygmomanometer Market?

Major companies operating in the sphygmomanometer market are A&D Company Ltd., American Diagnostic Corporation, Omron Healthcare Inc., Microlife Corporation, Beurer GmbH, CIGA Healthcare Ltd., Rossmax International Ltd., Rudolf Riester GmbH, Welch Allyn Inc., Koninklijke Philips N.V., Paul Hartmann AG, Spengler, Holtex Ltd., Timesco Healthcare Ltd., Bremed Ltd., iHealth Labs Inc., Contec Medical Systems Co. Ltd., SunTech Medical Inc., General Electric Company, Amico Group of Companies, HEINE Optotechnik GmbH and Co. KG, Hill-Rom Services Inc., Halma plc

Access The Complete Sphygmomanometer Market Report:

https://www.thebusinessresearchcompany.com/report/sphygmomanometer-global-market-report

Which Region Accounts For The Highest Share Of The Sphygmomanometer Market?

North America was the largest region in the sphygmomanometer market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global sphygmomanometer market during the forecast period. The regions covered in the sphygmomanometer market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Sphygmomanometer Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/report/sphygmomanometer-global-market-report

Browse Through More Reports Similar to the Global Sphygmomanometer Market 2026, By The Business Research Company

Digital Or Electrical Sphygmomanometer Market Report 2026

https://www.thebusinessresearchcompany.com/report/digital-or-electrical-sphygmomanometer-global-market-report

Spirometer Market Report 2026

https://www.thebusinessresearchcompany.com/report/spirometer-global-market-report

Bone Densitometer Market 2026

https://www.thebusinessresearchcompany.com/report/bone-densitometer-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Forecasted Market Size Trajectory Of The Sphygmomanometer Market From 2026 To 2030?

The sphygmomanometer market has demonstrated significant expansion recently. It is projected to increase from $3.2 billion in 2025 to $3.53 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.3%. The growth observed in prior periods can be attributed to the rising prevalence of hypertension, widespread use of mercury-based devices historically, increased screening in clinical settings, growth of primary healthcare facilities, and the adoption of manual and aneroid devices.

The sphygmomanometer market is projected to experience swift expansion over the coming years. This market is anticipated to reach $5.31 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.7%. Factors contributing to this growth during the projected timeframe include a greater need for remote patient observation, the wider embrace of connected healthcare tools, the broadening of telemedicine offerings, an increased emphasis on proactive cardiovascular health, and the ongoing substitution of mercury-based devices. Key developments anticipated within this forecast period encompass a surge in the uptake of digital blood pressure monitors, an escalating preference for at-home monitoring options, the expanding incorporation of data connectivity functionalities, the proliferation of portable and wearable setups, and a heightened emphasis on precise measurements and user-friendliness.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/sphygmomanometer-global-market-report

What Key Factors Are Shaping The Sphygmomanometer Market Landscape?

The increasing prevalence of chronic non-communicable diseases (NCDs) is projected to fuel the expansion of the sphygmomanometer market. These persistent health conditions, especially hypertension and cardiovascular disease, are characterized by slow progression and the need for continuous oversight and care. Hypertension, a significant global health concern and a primary risk factor for cardiovascular issues, underscores the importance of consistent blood-pressure monitoring for early detection and effective management. The rising incidence of these conditions is influenced by demographic and lifestyle factors such as an aging global population, poor dietary habits, insufficient physical activity, and increasing obesity rates, all contributing to a worldwide increase in blood-pressure irregularities. Sphygmomanometers play a crucial role in patient care by enabling prompt diagnosis, continuous monitoring, and enhanced cardiovascular risk management across both clinical and home-care environments. For instance, according to the World Health Organization (WHO), a Switzerland-based agency of the United Nations, in September 2025, an estimated 1.4 billion adults aged 30–79 were affected by hypertension in 2024, representing 33 percent of this age group, with two-thirds residing in low- and middle-income countries. Additionally, roughly 600 million individuals (44 percent) remained undiagnosed, while approximately 630 million (44 percent) had received diagnosis and treatment, highlighting the substantial global burden of the condition. Consequently, the growing burden of chronic NCDs is a significant catalyst for the growth of the sphygmomanometer market. The expansion in the number of ambulatory surgery centers is expected to drive the growth of the sphygmomanometer market moving forward. An Ambulatory Surgical Center (ASC) is a specialized medical facility where surgical procedures are performed without requiring an overnight hospital stay. These centers significantly rely on sphygmomanometers, also known as blood pressure cuffs, for monitoring patients’ vital signs before, during, and after surgical operations. For example, in July 2025, CliftonLarsonAllen LLP, a US-based professional services firm, reported that ambulatory surgery centers are increasing in size and usage, with over 10,000 facilities operating across the United States. The industry’s revenues are projected to grow from approximately USD 45 billion in 2024 to about USD 57 billion by 2030. Therefore, the increasing presence of ambulatory surgery centers is a key factor propelling the expansion of the sphygmomanometer market.

How Are Segments Identified Within The Sphygmomanometer Market Segment Framework?

The sphygmomanometer market covered in this report is segmented –

1) By Product: Electronic Sphygmomanometer, Aneroid Sphygmomanometer, Mercury Sphygmomanometer

2) By Configuration: Portable, Desk Mounted, Floor Standing, Wall Mounted

3) By Operation: Electric, Manual, Automatic, Semi-automatic

4) By End User: Hospitals, Ambulatory Surgical Centers And Clinics, Home Healthcare, Other End Users

Subsegments:

1) By Electronic Sphygmomanometer: Upper Arm Electronic Sphygmomanometer, Wrist Electronic Sphygmomanometer, Finger Electronic Sphygmomanometer

2) By Aneroid Sphygmomanometer: Manual Aneroid Sphygmomanometer, Digital Aneroid Sphygmomanometer

3) By Mercury Sphygmomanometer: Standard Mercury Sphygmomanometer, Portable Mercury Sphygmomanometer

What Market Trends Are Affecting The Sphygmomanometer Market?

Leading companies within the sphygmomanometer market are prioritizing the development of advanced automatic blood pressure monitoring solutions that integrate AI-driven diagnostic functionalities. These efforts aim to enhance measurement accuracy, aid in the early detection of cardiovascular abnormalities, and increase the ease of home-based health monitoring. AI-enabled automatic blood pressure monitors leverage machine-learning algorithms to scrutinize pulse-wave signals during cuff inflation, allowing these devices to identify irregular heart rhythms such as atrial fibrillation (AFib) while concurrently providing reliable systolic and diastolic readings. For instance, in November 2024, OMRON Healthcare, a Japan-based health equipment, software, and service provider, obtained FDA De Novo authorization for its subsequent generation home blood pressure monitor. This device features IntelliSense AFib, an AI-powered AFib detection algorithm that assesses more than 300 pulse-wave indices and exhibits high diagnostic precision, with clinical performance showing 95% sensitivity and 98% specificity. This innovation exemplifies the evolution of automatic oscillometric devices from basic blood-pressure measurement instruments into comprehensive cardiovascular screening technologies that support early detection, continuous monitoring, and enhanced clinical decision-making.

Who Are The Companies Competing Within The Sphygmomanometer Market?

Major companies operating in the sphygmomanometer market are A&D Company Ltd., American Diagnostic Corporation, Omron Healthcare Inc., Microlife Corporation, Beurer GmbH, CIGA Healthcare Ltd., Rossmax International Ltd., Rudolf Riester GmbH, Welch Allyn Inc., Koninklijke Philips N.V., Paul Hartmann AG, Spengler, Holtex Ltd., Timesco Healthcare Ltd., Bremed Ltd., iHealth Labs Inc., Contec Medical Systems Co. Ltd., SunTech Medical Inc., General Electric Company, Amico Group of Companies, HEINE Optotechnik GmbH and Co. KG, Hill-Rom Services Inc., Halma plc

Get The Full Sphygmomanometer Market Report:

https://www.thebusinessresearchcompany.com/report/sphygmomanometer-global-market-report

Which Region Leads The Sphygmomanometer Market In Overall Market Size?

North America was the largest region in the sphygmomanometer market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global sphygmomanometer market during the forecast period. The regions covered in the sphygmomanometer market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Sphygmomanometer Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/sphygmomanometer-global-market-report

Browse Through More Reports Similar to the Global Sphygmomanometer Market 2026, By The Business Research Company

Digital Or Electrical Sphygmomanometer Market Report 2026

https://www.thebusinessresearchcompany.com/report/digital-or-electrical-sphygmomanometer-global-market-report

Spirometer Market Report 2026

https://www.thebusinessresearchcompany.com/report/spirometer-global-market-report

Bone Densitometer Market 2026

https://www.thebusinessresearchcompany.com/report/bone-densitometer-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Much Is The Sphygmomanometer Market Expected To Grow In Terms Of Market Value Between 2026 And 2030?

The sphygmomanometer market size has seen rapid growth in recent years. It is expected to expand from $3.2 billion in 2025 to $3.53 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.3%. The growth observed in the past can be attributed to a higher incidence of hypertension, the historical widespread utilization of mercury-based devices, increased screening activities in clinical environments, the development of primary healthcare facilities, and the adoption of manual and aneroid devices.

The sphygmomanometer market size is anticipated to undergo significant expansion over the next few years. Its valuation is projected to reach $5.31 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 10.7%. This projected growth during the forecast period is driven by factors such as the increasing need for remote patient monitoring, the growing acceptance of connected healthcare devices, the expansion of telemedicine services, a heightened focus on preventive cardiovascular care, and the progressive replacement of mercury-based devices. Prominent developments expected in this period include the wider adoption of digital blood pressure monitoring devices, a surging demand for monitoring solutions used at home, the increasing integration of data connectivity functionalities, the development of more portable and wearable configurations, and an enhanced commitment to measurement accuracy and ease of use.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10396&type=smp

What Major Drivers Are Influencing Demand In The Sphygmomanometer Market?

The increasing prevalence of chronic non-communicable diseases (NCDs) is anticipated to drive the expansion of the sphygmomanometer market in the future. These enduring health conditions, particularly hypertension and cardiovascular disease, are characterized by gradual progression and necessitate continuous oversight and treatment. As a significant worldwide health issue and a key contributor to cardiovascular complications, hypertension underscores the critical need for routine blood pressure checks to ensure prompt diagnosis and successful therapy. The rising occurrence of these conditions is fueled by lifestyle elements like an aging global populace, poor nutritional habits, lack of physical activity, and increasing obesity, all of which contribute to elevated blood pressure irregularities globally. Sphygmomanometers play a vital role in patient management, facilitating prompt diagnosis, ongoing surveillance, and enhanced cardiovascular risk mitigation across both clinical and at-home care environments. For example, in September 2025, the World Health Organization (WHO), a United Nations agency based in Switzerland, highlighted the significant global impact of hypertension, reporting that an estimated 1.4 billion adults aged 30–79 were affected in 2024—constituting 33 percent of this demographic—with two-thirds living in low- and middle-income countries. Additionally, approximately 600 million individuals (44 percent) were undiagnosed, while about 630 million (44 percent) had received a diagnosis and treatment. Consequently, the increasing prevalence of chronic NCDs is propelling the expansion of the sphygmomanometer market.

What Major Segment Divisions Exist Within The Sphygmomanometer Market?

The sphygmomanometer market covered in this report is segmented –

1) By Product: Electronic Sphygmomanometer, Aneroid Sphygmomanometer, Mercury Sphygmomanometer

2) By Configuration: Portable, Desk Mounted, Floor Standing, Wall Mounted

3) By Operation: Electric, Manual, Automatic, Semi-automatic

4) By End User: Hospitals, Ambulatory Surgical Centers And Clinics, Home Healthcare, Other End Users

Subsegments:

1) By Electronic Sphygmomanometer: Upper Arm Electronic Sphygmomanometer, Wrist Electronic Sphygmomanometer, Finger Electronic Sphygmomanometer

2) By Aneroid Sphygmomanometer: Manual Aneroid Sphygmomanometer, Digital Aneroid Sphygmomanometer

3) By Mercury Sphygmomanometer: Standard Mercury Sphygmomanometer, Portable Mercury Sphygmomanometer

How Are Trends Shaping The Direction Of The Sphygmomanometer Market?

Major companies operating in the sphygmomanometer market are prioritizing the development of advanced automatic blood pressure monitoring solutions, integrating AI-driven diagnostic features to enhance measurement accuracy, support the early identification of cardiovascular abnormalities, and improve the convenience of home-based health monitoring. These AI-enabled automatic blood pressure monitors utilize machine-learning algorithms to analyze pulse-wave signals during cuff inflation, which enables the device to detect irregular heart rhythms like atrial fibrillation (AFib) while concurrently providing reliable systolic and diastolic readings. For instance, in November 2024, OMRON Healthcare, a Japan-based health equipment, software, and service provider, secured FDA De Novo authorization for its next-generation home blood pressure monitor. This device is equipped with IntelliSense AFib, an AI-powered AFib detection algorithm that evaluates more than 300 pulse-wave indices and demonstrates high diagnostic accuracy, with clinical performance showing 95% sensitivity and 98% specificity. This innovation underscores how automatic oscillometric devices are evolving from simple blood-pressure measurement tools into comprehensive cardiovascular screening technologies that support early detection, continuous monitoring, and improved clinical decision-making.

Which Companies Are Leading Innovation In The Sphygmomanometer Market?

Major companies operating in the sphygmomanometer market are A&D Company Ltd., American Diagnostic Corporation, Omron Healthcare Inc., Microlife Corporation, Beurer GmbH, CIGA Healthcare Ltd., Rossmax International Ltd., Rudolf Riester GmbH, Welch Allyn Inc., Koninklijke Philips N.V., Paul Hartmann AG, Spengler, Holtex Ltd., Timesco Healthcare Ltd., Bremed Ltd., iHealth Labs Inc., Contec Medical Systems Co. Ltd., SunTech Medical Inc., General Electric Company, Amico Group of Companies, HEINE Optotechnik GmbH and Co. KG, Hill-Rom Services Inc., Halma plc

Read the full sphygmomanometer market report here:

https://www.thebusinessresearchcompany.com/report/sphygmomanometer-global-market-report

Which Region Shows The Strongest Potential For Future Growth In The Sphygmomanometer Market?

North America was the largest region in the sphygmomanometer market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global sphygmomanometer market during the forecast period. The regions covered in the sphygmomanometer market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Sphygmomanometer Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=10396&type=smp

Browse Through More Reports Similar to the Global Sphygmomanometer Market 2026, By The Business Research Company

Digital Or Electrical Sphygmomanometer Market Report 2026

https://www.thebusinessresearchcompany.com/report/digital-or-electrical-sphygmomanometer-global-market-report

Spirometer Market Report 2026

https://www.thebusinessresearchcompany.com/report/spirometer-global-market-report

Bone Densitometer Market 2026

https://www.thebusinessresearchcompany.com/report/bone-densitometer-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Much Is The Sphygmomanometer Market Expected To Grow In Terms Of Market Value Between 2026 And 2030?

The sphygmomanometer market size has seen rapid growth in recent years. It is expected to expand from $3.2 billion in 2025 to $3.53 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.3%. The growth observed in the past can be attributed to a higher incidence of hypertension, the historical widespread utilization of mercury-based devices, increased screening activities in clinical environments, the development of primary healthcare facilities, and the adoption of manual and aneroid devices.

The sphygmomanometer market size is anticipated to undergo significant expansion over the next few years. Its valuation is projected to reach $5.31 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 10.7%. This projected growth during the forecast period is driven by factors such as the increasing need for remote patient monitoring, the growing acceptance of connected healthcare devices, the expansion of telemedicine services, a heightened focus on preventive cardiovascular care, and the progressive replacement of mercury-based devices. Prominent developments expected in this period include the wider adoption of digital blood pressure monitoring devices, a surging demand for monitoring solutions used at home, the increasing integration of data connectivity functionalities, the development of more portable and wearable configurations, and an enhanced commitment to measurement accuracy and ease of use.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10396&type=smp

What Major Drivers Are Influencing Demand In The Sphygmomanometer Market?

The increasing prevalence of chronic non-communicable diseases (NCDs) is anticipated to drive the expansion of the sphygmomanometer market in the future. These enduring health conditions, particularly hypertension and cardiovascular disease, are characterized by gradual progression and necessitate continuous oversight and treatment. As a significant worldwide health issue and a key contributor to cardiovascular complications, hypertension underscores the critical need for routine blood pressure checks to ensure prompt diagnosis and successful therapy. The rising occurrence of these conditions is fueled by lifestyle elements like an aging global populace, poor nutritional habits, lack of physical activity, and increasing obesity, all of which contribute to elevated blood pressure irregularities globally. Sphygmomanometers play a vital role in patient management, facilitating prompt diagnosis, ongoing surveillance, and enhanced cardiovascular risk mitigation across both clinical and at-home care environments. For example, in September 2025, the World Health Organization (WHO), a United Nations agency based in Switzerland, highlighted the significant global impact of hypertension, reporting that an estimated 1.4 billion adults aged 30–79 were affected in 2024—constituting 33 percent of this demographic—with two-thirds living in low- and middle-income countries. Additionally, approximately 600 million individuals (44 percent) were undiagnosed, while about 630 million (44 percent) had received a diagnosis and treatment. Consequently, the increasing prevalence of chronic NCDs is propelling the expansion of the sphygmomanometer market.

What Major Segment Divisions Exist Within The Sphygmomanometer Market?

The sphygmomanometer market covered in this report is segmented –

1) By Product: Electronic Sphygmomanometer, Aneroid Sphygmomanometer, Mercury Sphygmomanometer

2) By Configuration: Portable, Desk Mounted, Floor Standing, Wall Mounted

3) By Operation: Electric, Manual, Automatic, Semi-automatic

4) By End User: Hospitals, Ambulatory Surgical Centers And Clinics, Home Healthcare, Other End Users

Subsegments:

1) By Electronic Sphygmomanometer: Upper Arm Electronic Sphygmomanometer, Wrist Electronic Sphygmomanometer, Finger Electronic Sphygmomanometer

2) By Aneroid Sphygmomanometer: Manual Aneroid Sphygmomanometer, Digital Aneroid Sphygmomanometer

3) By Mercury Sphygmomanometer: Standard Mercury Sphygmomanometer, Portable Mercury Sphygmomanometer

How Are Trends Shaping The Direction Of The Sphygmomanometer Market?

Major companies operating in the sphygmomanometer market are prioritizing the development of advanced automatic blood pressure monitoring solutions, integrating AI-driven diagnostic features to enhance measurement accuracy, support the early identification of cardiovascular abnormalities, and improve the convenience of home-based health monitoring. These AI-enabled automatic blood pressure monitors utilize machine-learning algorithms to analyze pulse-wave signals during cuff inflation, which enables the device to detect irregular heart rhythms like atrial fibrillation (AFib) while concurrently providing reliable systolic and diastolic readings. For instance, in November 2024, OMRON Healthcare, a Japan-based health equipment, software, and service provider, secured FDA De Novo authorization for its next-generation home blood pressure monitor. This device is equipped with IntelliSense AFib, an AI-powered AFib detection algorithm that evaluates more than 300 pulse-wave indices and demonstrates high diagnostic accuracy, with clinical performance showing 95% sensitivity and 98% specificity. This innovation underscores how automatic oscillometric devices are evolving from simple blood-pressure measurement tools into comprehensive cardiovascular screening technologies that support early detection, continuous monitoring, and improved clinical decision-making.

Which Companies Are Leading Innovation In The Sphygmomanometer Market?

Major companies operating in the sphygmomanometer market are A&D Company Ltd., American Diagnostic Corporation, Omron Healthcare Inc., Microlife Corporation, Beurer GmbH, CIGA Healthcare Ltd., Rossmax International Ltd., Rudolf Riester GmbH, Welch Allyn Inc., Koninklijke Philips N.V., Paul Hartmann AG, Spengler, Holtex Ltd., Timesco Healthcare Ltd., Bremed Ltd., iHealth Labs Inc., Contec Medical Systems Co. Ltd., SunTech Medical Inc., General Electric Company, Amico Group of Companies, HEINE Optotechnik GmbH and Co. KG, Hill-Rom Services Inc., Halma plc

Read the full sphygmomanometer market report here:

https://www.thebusinessresearchcompany.com/report/sphygmomanometer-global-market-report

Which Region Shows The Strongest Potential For Future Growth In The Sphygmomanometer Market?

North America was the largest region in the sphygmomanometer market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global sphygmomanometer market during the forecast period. The regions covered in the sphygmomanometer market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Sphygmomanometer Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=10396&type=smp

Browse Through More Reports Similar to the Global Sphygmomanometer Market 2026, By The Business Research Company

Digital Or Electrical Sphygmomanometer Market Report 2026

https://www.thebusinessresearchcompany.com/report/digital-or-electrical-sphygmomanometer-global-market-report

Spirometer Market Report 2026

https://www.thebusinessresearchcompany.com/report/spirometer-global-market-report

Bone Densitometer Market 2026

https://www.thebusinessresearchcompany.com/report/bone-densitometer-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Much Is The Sphygmomanometer Market Expected To Grow In Terms Of Market Value Between 2026 And 2030?

The sphygmomanometer market size has seen rapid growth in recent years. It is expected to expand from $3.2 billion in 2025 to $3.53 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.3%. The growth observed in the past can be attributed to a higher incidence of hypertension, the historical widespread utilization of mercury-based devices, increased screening activities in clinical environments, the development of primary healthcare facilities, and the adoption of manual and aneroid devices.

The sphygmomanometer market size is anticipated to undergo significant expansion over the next few years. Its valuation is projected to reach $5.31 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 10.7%. This projected growth during the forecast period is driven by factors such as the increasing need for remote patient monitoring, the growing acceptance of connected healthcare devices, the expansion of telemedicine services, a heightened focus on preventive cardiovascular care, and the progressive replacement of mercury-based devices. Prominent developments expected in this period include the wider adoption of digital blood pressure monitoring devices, a surging demand for monitoring solutions used at home, the increasing integration of data connectivity functionalities, the development of more portable and wearable configurations, and an enhanced commitment to measurement accuracy and ease of use.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10396&type=smp

What Major Drivers Are Influencing Demand In The Sphygmomanometer Market?

The increasing prevalence of chronic non-communicable diseases (NCDs) is anticipated to drive the expansion of the sphygmomanometer market in the future. These enduring health conditions, particularly hypertension and cardiovascular disease, are characterized by gradual progression and necessitate continuous oversight and treatment. As a significant worldwide health issue and a key contributor to cardiovascular complications, hypertension underscores the critical need for routine blood pressure checks to ensure prompt diagnosis and successful therapy. The rising occurrence of these conditions is fueled by lifestyle elements like an aging global populace, poor nutritional habits, lack of physical activity, and increasing obesity, all of which contribute to elevated blood pressure irregularities globally. Sphygmomanometers play a vital role in patient management, facilitating prompt diagnosis, ongoing surveillance, and enhanced cardiovascular risk mitigation across both clinical and at-home care environments. For example, in September 2025, the World Health Organization (WHO), a United Nations agency based in Switzerland, highlighted the significant global impact of hypertension, reporting that an estimated 1.4 billion adults aged 30–79 were affected in 2024—constituting 33 percent of this demographic—with two-thirds living in low- and middle-income countries. Additionally, approximately 600 million individuals (44 percent) were undiagnosed, while about 630 million (44 percent) had received a diagnosis and treatment. Consequently, the increasing prevalence of chronic NCDs is propelling the expansion of the sphygmomanometer market.

What Major Segment Divisions Exist Within The Sphygmomanometer Market?

The sphygmomanometer market covered in this report is segmented –

1) By Product: Electronic Sphygmomanometer, Aneroid Sphygmomanometer, Mercury Sphygmomanometer

2) By Configuration: Portable, Desk Mounted, Floor Standing, Wall Mounted

3) By Operation: Electric, Manual, Automatic, Semi-automatic

4) By End User: Hospitals, Ambulatory Surgical Centers And Clinics, Home Healthcare, Other End Users

Subsegments:

1) By Electronic Sphygmomanometer: Upper Arm Electronic Sphygmomanometer, Wrist Electronic Sphygmomanometer, Finger Electronic Sphygmomanometer

2) By Aneroid Sphygmomanometer: Manual Aneroid Sphygmomanometer, Digital Aneroid Sphygmomanometer

3) By Mercury Sphygmomanometer: Standard Mercury Sphygmomanometer, Portable Mercury Sphygmomanometer

How Are Trends Shaping The Direction Of The Sphygmomanometer Market?

Major companies operating in the sphygmomanometer market are prioritizing the development of advanced automatic blood pressure monitoring solutions, integrating AI-driven diagnostic features to enhance measurement accuracy, support the early identification of cardiovascular abnormalities, and improve the convenience of home-based health monitoring. These AI-enabled automatic blood pressure monitors utilize machine-learning algorithms to analyze pulse-wave signals during cuff inflation, which enables the device to detect irregular heart rhythms like atrial fibrillation (AFib) while concurrently providing reliable systolic and diastolic readings. For instance, in November 2024, OMRON Healthcare, a Japan-based health equipment, software, and service provider, secured FDA De Novo authorization for its next-generation home blood pressure monitor. This device is equipped with IntelliSense AFib, an AI-powered AFib detection algorithm that evaluates more than 300 pulse-wave indices and demonstrates high diagnostic accuracy, with clinical performance showing 95% sensitivity and 98% specificity. This innovation underscores how automatic oscillometric devices are evolving from simple blood-pressure measurement tools into comprehensive cardiovascular screening technologies that support early detection, continuous monitoring, and improved clinical decision-making.

Which Companies Are Leading Innovation In The Sphygmomanometer Market?

Major companies operating in the sphygmomanometer market are A&D Company Ltd., American Diagnostic Corporation, Omron Healthcare Inc., Microlife Corporation, Beurer GmbH, CIGA Healthcare Ltd., Rossmax International Ltd., Rudolf Riester GmbH, Welch Allyn Inc., Koninklijke Philips N.V., Paul Hartmann AG, Spengler, Holtex Ltd., Timesco Healthcare Ltd., Bremed Ltd., iHealth Labs Inc., Contec Medical Systems Co. Ltd., SunTech Medical Inc., General Electric Company, Amico Group of Companies, HEINE Optotechnik GmbH and Co. KG, Hill-Rom Services Inc., Halma plc

Read the full sphygmomanometer market report here:

https://www.thebusinessresearchcompany.com/report/sphygmomanometer-global-market-report

Which Region Shows The Strongest Potential For Future Growth In The Sphygmomanometer Market?

North America was the largest region in the sphygmomanometer market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global sphygmomanometer market during the forecast period. The regions covered in the sphygmomanometer market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Sphygmomanometer Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=10396&type=smp

Browse Through More Reports Similar to the Global Sphygmomanometer Market 2026, By The Business Research Company

Digital Or Electrical Sphygmomanometer Market Report 2026

https://www.thebusinessresearchcompany.com/report/digital-or-electrical-sphygmomanometer-global-market-report

Spirometer Market Report 2026

https://www.thebusinessresearchcompany.com/report/spirometer-global-market-report

Bone Densitometer Market 2026

https://www.thebusinessresearchcompany.com/report/bone-densitometer-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the worker heat stress monitoring wearable market from 2026–2035 with trusted insights from The Business Research Company

What total market size is anticipated for the Sphygmomanometer Market in 2030?

The sphygmomanometer market has experienced substantial expansion in recent years. It is forecast to grow from $3.2 billion in 2025 to $3.53 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 10.3%. Historically, this market’s growth can be ascribed to factors such as the increasing incidence of hypertension, the past widespread utilization of mercury-based devices, enhanced screening activities in clinical settings, the expansion of primary healthcare facilities, and the adoption of both manual and aneroid devices.

The sphygmomanometer market is projected for swift expansion over the coming years. By 2030, its valuation is anticipated to reach $5.31 billion, exhibiting a compound annual growth rate (CAGR) of 10.7%. This anticipated growth is driven by factors such as a heightened need for remote patient observation, the increasing integration of internet-enabled healthcare tools, the broadening of telehealth offerings, a stronger emphasis on proactive cardiovascular health, and the ongoing substitution of traditional mercury devices. Key developments during this timeframe are expected to encompass the wider use of digital blood pressure monitors, an increased preference for at-home monitoring options, the expanding incorporation of data communication capabilities, the availability of more portable and body-worn designs, and a heightened commitment to ensuring precise readings and user-friendliness.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10396&type=smp

What Drivers Are Influencing Production Trends In The Sphygmomanometer Market?

The increasing prevalence of chronic non-communicable diseases (NCDs) is anticipated to fuel the expansion of the sphygmomanometer market in the future. These conditions, particularly hypertension and cardiovascular disease, are long-term health issues that develop gradually, necessitating continuous oversight and management. Hypertension, a significant worldwide health concern and a primary contributor to cardiovascular problems, underscores the importance of consistent blood-pressure evaluation for early detection and effective intervention. The escalating occurrence of such conditions stems from lifestyle elements like an aging global populace, poor dietary habits, lack of physical activity, and rising obesity levels, all of which contribute to a greater incidence of blood-pressure irregularities across the globe. Sphygmomanometers are vital for patient care, facilitating prompt diagnosis, ongoing monitoring, and better management of cardiovascular risks in both hospital and home environments. For example, in September 2025, the World Health Organization (WHO), a Switzerland-based agency of the United Nations, reported on the extensive global impact of hypertension, noting that an estimated 1.4 billion adults aged 30–79 were affected in 2024—making up 33 percent of this age group—with two-thirds residing in low- and middle-income countries. Additionally, approximately 600 million individuals (44 percent) were undiagnosed, and about 630 million (44 percent) received both diagnosis and treatment. Consequently, the increasing prevalence of chronic NCDs is propelling the growth of the sphygmomanometer market.

Which Segments Are Gaining Traction In The Sphygmomanometer Market?

The sphygmomanometer market covered in this report is segmented –

1) By Product: Electronic Sphygmomanometer, Aneroid Sphygmomanometer, Mercury Sphygmomanometer

2) By Configuration: Portable, Desk Mounted, Floor Standing, Wall Mounted

3) By Operation: Electric, Manual, Automatic, Semi-automatic

4) By End User: Hospitals, Ambulatory Surgical Centers And Clinics, Home Healthcare, Other End Users

Subsegments:

1) By Electronic Sphygmomanometer: Upper Arm Electronic Sphygmomanometer, Wrist Electronic Sphygmomanometer, Finger Electronic Sphygmomanometer

2) By Aneroid Sphygmomanometer: Manual Aneroid Sphygmomanometer, Digital Aneroid Sphygmomanometer

3) By Mercury Sphygmomanometer: Standard Mercury Sphygmomanometer, Portable Mercury Sphygmomanometer

What Trends Are Expected To Impact The Competitive Landscape Of The Sphygmomanometer Market?

Major companies in the sphygmomanometer market are prioritizing the development of advanced automatic blood pressure monitoring solutions that integrate AI-driven diagnostic functionalities. These efforts aim to enhance measurement accuracy, facilitate early detection of cardiovascular abnormalities, and improve the convenience of home-based health monitoring. AI-enabled automatic blood pressure monitors utilize machine-learning algorithms to scrutinize pulse-wave signals during cuff inflation, allowing the apparatus to identify irregular heart rhythms such as atrial fibrillation (AFib) while delivering dependable systolic and diastolic readings. For instance, in November 2024, OMRON Healthcare, a Japan-based health equipment, software, and service provider, secured FDA De Novo authorization for its next-generation home blood pressure monitor featuring IntelliSense AFib, an AI-powered AFib detection algorithm that analyzes over 300 pulse-wave indices and exhibits high diagnostic precision, with clinical performance showing 95% sensitivity and 98% specificity. This innovation exemplifies the evolution of automatic oscillometric devices from simple blood-pressure measurement tools into comprehensive cardiovascular screening technologies that support early detection, continuous monitoring, and refined clinical decision-making.

Who Are The Core Companies Influencing Trends In The Sphygmomanometer Market?

Major companies operating in the sphygmomanometer market are A&D Company Ltd., American Diagnostic Corporation, Omron Healthcare Inc., Microlife Corporation, Beurer GmbH, CIGA Healthcare Ltd., Rossmax International Ltd., Rudolf Riester GmbH, Welch Allyn Inc., Koninklijke Philips N.V., Paul Hartmann AG, Spengler, Holtex Ltd., Timesco Healthcare Ltd., Bremed Ltd., iHealth Labs Inc., Contec Medical Systems Co. Ltd., SunTech Medical Inc., General Electric Company, Amico Group of Companies, HEINE Optotechnik GmbH and Co. KG, Hill-Rom Services Inc., Halma plc

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/sphygmomanometer-global-market-report

Which Region Is Projected To Lead The Sphygmomanometer Market During The Forecast Period?

North America was the largest region in the sphygmomanometer market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global sphygmomanometer market during the forecast period. The regions covered in the sphygmomanometer market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Sphygmomanometer Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=10396&type=smp

Browse Through More Reports Similar to the Global Sphygmomanometer Market 2026, By The Business Research Company

Digital Or Electrical Sphygmomanometer Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/digital-or-electrical-sphygmomanometer-global-market-report

Spirometer Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/spirometer-global-market-report

Bone Densitometer Market 2026

https://www.thebusinessresearchcompany.com/report/bone-densitometer-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Uncover key drivers, emerging technologies, and competitive movements shaping the sphygmomanometer market from 2025–2034 with trusted insights from The Business Research Company

How Will The Sphygmomanometer Market Size Evolve Between Now And 2029?

The sphygmomanometer market has experienced substantial growth in recent years. It is forecast to increase from $2.98 billion in 2024 to $3.2 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.5%. This historical expansion can be attributed to factors such as construction industry growth, agricultural sector demand, its versatility and reach, various infrastructure projects, increased efficiency in material handling, and the demand from the rental market.

The sphygmomanometer market is anticipated to experience substantial expansion in the coming years. Projections indicate it will reach a value of $4.77 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 10.5%. This projected growth is driven by several factors, including renewable energy initiatives, increasing urbanization and vertical construction, advancements in precision agriculture, a heightened emphasis on environmental sustainability, adherence to safety regulations, and a worldwide economic recovery. Key trends expected during this period encompass product innovation, the development of compact and agile designs, the introduction of electric and hybrid models, the integration of telematics and IoT technologies, and the adoption of high-strength materials.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10396&type=smp

Which Key Drivers Are Powering Growth In The Sphygmomanometer Market?

The rising occurrence of long-term health conditions like diabetes, high blood pressure, and ischemic heart disease is anticipated to drive the expansion of the sphygmomanometer market in the future. These chronic conditions are persistent health issues that necessitate continuous medical supervision and care. Sphygmomanometers serve in the management of chronic diseases and can assist in diagnosing, monitoring various cardiovascular ailments, and detecting underlying reasons for hypertension, including renal artery stenosis or pheochromocytoma, through observation of fluid retention. For example, data from December 2022, reported by the Journal of the American College of Cardiology (JACC), a peer-reviewed medical publication from the US by the American College of Cardiology, indicated that ischemic heart disease was responsible for 9.44 million cardiovascular fatalities in 2021. Furthermore, hypertensive heart disease contributed to 1.41 million deaths, and pulmonary arterial hypertension to 23,300 deaths, respectively. Consequently, the growing incidence of chronic conditions like diabetes, hypertension, and ischemic heart disease is fueling the expansion of the sphygmomanometer market.

How Is The Global Sphygmomanometer Market Structured By Key Segments?

The sphygmomanometermarket covered in this report is segmented –

1) By Product: Electronic Sphygmomanometer, Aneroid Sphygmomanometer, Mercury Sphygmomanometer

2) By Configuration: Portable, Desk Mounted, Floor Standing, Wall Mounted

3) By Operation: Electric, Manual, Automatic, Semi-automatic

4) By End User: Hospitals, Ambulatory Surgical Centers And Clinics, Home Healthcare, Other End Users

Subsegments:

1) By Electronic Sphygmomanometer: Upper Arm Electronic Sphygmomanometer, Wrist Electronic Sphygmomanometer, Finger Electronic Sphygmomanometer

2) By Aneroid Sphygmomanometer: Manual Aneroid Sphygmomanometer, Digital Aneroid Sphygmomanometer

3) By Mercury Sphygmomanometer: Standard Mercury Sphygmomanometer, Portable Mercury Sphygmomanometer

What Future-Focused Trends Are Anticipated In The Sphygmomanometer Market?

Major companies operating in the sphygmomanometer market are focused on developing innovative products such as automatic blood pressure monitors to enhance accuracy, improve user experience, and facilitate continuous monitoring of blood pressure for better management of hypertension and cardiovascular health. Automatic blood pressure monitors are electronic devices that measure blood pressure using an inflatable cuff and oscillometric technology, providing accurate readings of systolic and diastolic pressures along with pulse rate for easy self-monitoring at home. For instance, in February 2022, InBody, a South Korea-based company that provides body composition technology, launched BP 170. The BP 170 is an automatic blood pressure monitor designed for home use, utilizing oscillometric technology to provide accurate measurements of systolic and diastolic blood pressure along with pulse rate. It features a user-friendly one-touch cuff for easy application, a large display for enhanced visibility, and the capability to store readings for multiple users, making it ideal for family health monitoring. Additionally, the device is clinically validated, ensuring reliable results that can help users effectively manage their cardiovascular health.

Which Companies Hold A Competitive Edge In The Sphygmomanometer Market?

Major companies operating in the sphygmomanometer market include A&D Company Ltd., American Diagnostic Corporation, Omron Healthcare Inc., Microlife Corporation, Acoma Medical Industry Co. Ltd., Beurer GmbH, General Electric Company, Amico Group of Companies, CIGA Healthcare Ltd., HEINE Optotechnik GmbH and Co. KG, Rossmax International Ltd., Rudolf Riester GmbH, Welch Allyn Inc., Koninklijke Philips N.V., Paul Hartmann AG, 3B Scientific, Hill-Rom Services Inc., Sklar Surgical Instruments, Spengler, Holtex Ltd., Timesco Healthcare Ltd., Bremed Ltd., iHealth Labs Inc., Contec Medical Systems Co. Ltd., Halma plc, SunTech Medical Inc.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/sphygmomanometer-global-market-report

Which Region Is Expected To Lead The Sphygmomanometer Market In The Next Few Years?

North America was the largest region in the sphygmomanometer market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global sphygmomanometer market during the forecast period. The regions covered in the sphygmomanometer market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=10396&type=smp

Browse Through More Reports Similar to the Global Sphygmomanometer Market 2025, By The Business Research Company

Blood Glucose Meters Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blood-glucose-meters-global-market-report

Blood Transfusion Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report

3D Printed Medical Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/3d-printed-medical-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Expected Total Market Size Of The Sphygmomanometer Industry By The Forecast Year 2029?

Having demonstrated robust expansion lately, the sphygmomanometer sector is projected to increase its valuation from $2.98 billion in 2024 to $3.2 billion in the subsequent year, reflecting a consistent compound annual growth rate of 7.5%; this historical upward trend is fundamentally supported by the expansion observed within the construction industry, substantial requirements from the agricultural domain, the product’s widespread utility and accessibility, considerable investment in infrastructure initiatives, improvements in how materials are managed and transported, and the strong pull from the equipment rental pool.

Anticipation is for substantial expansion within the sphygmomanometer sector over the ensuing years, projecting a trajectory to reach a valuation of $4.77 billion by 2029, fueled by a compound annual growth rate (CAGR) of 10.5%; this forecasted ascendance is primarily driven by factors such as advancements in renewable energy infrastructure, increasing urbanization paired with vertical building initiatives, the adoption of precise agricultural methods, a heightened commitment to ecological responsibility, adherence to stringent safety mandates, and the general recuperation of worldwide economic activity; furthermore, key directional shifts expected during this projection timeframe encompass continuous advancements in product offerings, the development of designs prized for their small footprint and ease of mobility, the emergence of electrically powered and hybrid power options, the incorporation of telematics and internet of things (IoT) technologies, alongside the increased utilization of robust, high-strength raw materials.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10396&type=smp

Which Major Market Drivers Are Shaping The Future Of The Sphygmomanometer Market?

The sustained rise in long-term medical conditions, including diabetes, high blood pressure, and coronary artery disease, is anticipated to boost the sphygmomanometer market’s expansion moving ahead; these enduring ailments necessitate continuous medical oversight and treatment, for which sphygmomanometers are essential tools—not only for diagnosing and tracking other heart and blood vessel issues but also for detecting underlying sources of elevated blood pressure, like obstructions in the renal arteries or pheochromocytoma, via the observation of fluid retention; to illustrate the scope, data from the Journal of the American College of Cardiology (JACC), an American College of Cardiology publication from the U.S., revealed that in 2021, ischemic heart disease resulted in 9.44 million fatalities related to cardiovascular issues, with hypertensive heart disease contributing an additional 1.41 million deaths and pulmonary arterial hypertension accounting for 23,300 fatalities, hence the mounting incidence of persistent conditions such as diabetes, hypertension, and ischemic heart disease serves as a key factor underpinning the market growth for sphygmomanometers.

What Are The Segment Types Shaping The Sphygmomanometer Market?

The sphygmomanometermarket covered in this report is segmented –

1) By Product: Electronic Sphygmomanometer, Aneroid Sphygmomanometer, Mercury Sphygmomanometer

2) By Configuration: Portable, Desk Mounted, Floor Standing, Wall Mounted

3) By Operation: Electric, Manual, Automatic, Semi-automatic

4) By End User: Hospitals, Ambulatory Surgical Centers And Clinics, Home Healthcare, Other End Users

Subsegments:

1) By Electronic Sphygmomanometer: Upper Arm Electronic Sphygmomanometer, Wrist Electronic Sphygmomanometer, Finger Electronic Sphygmomanometer

2) By Aneroid Sphygmomanometer: Manual Aneroid Sphygmomanometer, Digital Aneroid Sphygmomanometer

3) By Mercury Sphygmomanometer: Standard Mercury Sphygmomanometer, Portable Mercury Sphygmomanometer

What Trends Are Expected To Drive The Sphygmomanometer Market?

Leading enterprises within the sphygmomanometer sector are prioritizing the creation of novel solutions, such as automated blood pressure measurement devices, aiming to elevate precision, refine consumer interaction, and enable ongoing oversight of blood pressure for superior management of both hypertension and overall cardiovascular wellness. These electronic apparatuses, which employ an inflatable cuff and oscillometric methodology to ascertain blood pressure, furnish precise determinations of both systolic and diastolic figures alongside the heart rate, thereby simplifying at-home self-assessment. A relevant illustration is the introduction of the BP 170 in February 2022 by InBody, a South Korean firm specializing in body composition technology; this specific automated monitor, engineered for domestic environments, leverages oscillometric science to yield exact systolic and diastolic readings plus pulse data. Its design incorporates a straightforward single-button cuff for effortless fitting, an expansive screen for improved readability, and the capacity to retain measurement histories for several distinct individuals, rendering it highly suitable for tracking the health of an entire household. Furthermore, the assurance of clinical validation confirms the dependability of the data provided by this instrument, empowering users in the proactive stewardship of their heart health.

Who Are The Top Performing Companies In The Sphygmomanometer Market In Recent Years?

Major companies operating in the sphygmomanometer market include A&D Company Ltd., American Diagnostic Corporation, Omron Healthcare Inc., Microlife Corporation, Acoma Medical Industry Co. Ltd., Beurer GmbH, General Electric Company, Amico Group of Companies, CIGA Healthcare Ltd., HEINE Optotechnik GmbH and Co. KG, Rossmax International Ltd., Rudolf Riester GmbH, Welch Allyn Inc., Koninklijke Philips N.V., Paul Hartmann AG, 3B Scientific, Hill-Rom Services Inc., Sklar Surgical Instruments, Spengler, Holtex Ltd., Timesco Healthcare Ltd., Bremed Ltd., iHealth Labs Inc., Contec Medical Systems Co. Ltd., Halma plc, SunTech Medical Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/sphygmomanometer-global-market-report

What Are The Key Regional Factors Influencing The Sphygmomanometer Market Growth?

North America was the largest region in the sphygmomanometer market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global sphygmomanometer market during the forecast period. The regions covered in the sphygmomanometer market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Sphygmomanometer Market Report:

https://www.thebusinessresearchcompany.com/customise?id=10396&type=smp

Browse Through More Reports Similar to the Global Sphygmomanometer Market 2025, By The Business Research Company

Blood Glucose Meters Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blood-glucose-meters-global-market-report

Blood Transfusion Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report

3D Printed Medical Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/3d-printed-medical-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model